November 16, 2021 Quanterix’ Simoa® Technology Powers Advances in Alzheimer’s Disease Research Presented at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference read more
November 4, 2021 Quanterix Corporation Releases Operating Results for Third Quarter of 2021 read more
October 11, 2021 Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease read more
September 20, 2021 Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories read more
September 13, 2021 Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test read more
September 11, 2021 Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings” read more
August 10, 2021 Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference read more
August 6, 2021 Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021 read more